Search research articles
Contact Us
Filters
Showing results (611-620 of 631) with videos related to
Page
of 64
Sort By:
Oncoimmunology
|
May 8, 2015
Phase I trial of adoptively transferred tumor-infiltrating lymphocyte immunotherapy following concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
Jiang Li, Qiu-Yan Chen, Jia He, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 6, 2023
Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial
Shan-Shan Guo, Jin-Hao Yang, Xue-Song Sun, et al.
BMC Cancer
|
December 18, 2015
The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapy
Shan-Shan Guo, Lin-Quan Tang, Lu Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 9, 2014
High-sensitivity C-reactive protein complements plasma Epstein-Barr virus deoxyribonucleic acid prognostication in nasopharyngeal carcinoma: a large-scale retrospective and prospective cohort study
Lin-Quan Tang, Chao-Feng Li, Qiu-Yan Chen, et al.
BMC Cancer
|
August 12, 2014
Elevated levels of plasma D-dimer predict a worse outcome in patients with nasopharyngeal carcinoma
Wen-Hui Chen, Lin-Quan Tang, Feng-Wei Wang, et al.
BMC Cancer
|
February 2, 2018
Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRT
Shan-Shan Guo, Wen Hu, Qiu-Yan Chen, et al.
Oncotarget
|
April 23, 2016
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in stage III-IVb nasopharyngeal carcinoma patients with Epstein-Barr virus DNA ≥4000 copies/ml: a matched study
Shan-Shan Guo, Lin-Quan Tang, Qiu-Yan Chen, et al.
Journal of Cancer
|
November 19, 2019
The impact of Adult Comorbidity Evaluation-27 on the clinical outcome of elderly nasopharyngeal carcinoma patients treated with chemoradiotherapy or radiotherapy: a matched cohort analysis
Yue-Feng Wen, Xue-Song Sun, Li Yuan, et al.
Endoscopy
|
October 13, 2025
A rural-to-center artificial intelligence model for diagnosing Helicobacter pylori infection and premalignant gastric conditions using endoscopy images captured in routine practice
Tsung-Hsien Chiang, Yen-Ning Hsu, Min-Han Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2022
Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority Trial
Xiao-Yun Li, Dong-Hua Luo, Ling Guo, et al.
Page
of 64
Search research articles
Search
Showing results (611-620 of 631) with videos related to
Sort By:
Page
of 64
Oncoimmunology
|
May 8, 2015
Phase I trial of adoptively transferred tumor-infiltrating lymphocyte immunotherapy following concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
Jiang Li, Qiu-Yan Chen, Jia He, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 6, 2023
Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial
Shan-Shan Guo, Jin-Hao Yang, Xue-Song Sun, et al.
BMC Cancer
|
December 18, 2015
The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapy
Shan-Shan Guo, Lin-Quan Tang, Lu Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 9, 2014
High-sensitivity C-reactive protein complements plasma Epstein-Barr virus deoxyribonucleic acid prognostication in nasopharyngeal carcinoma: a large-scale retrospective and prospective cohort study
Lin-Quan Tang, Chao-Feng Li, Qiu-Yan Chen, et al.
BMC Cancer
|
August 12, 2014
Elevated levels of plasma D-dimer predict a worse outcome in patients with nasopharyngeal carcinoma
Wen-Hui Chen, Lin-Quan Tang, Feng-Wei Wang, et al.
BMC Cancer
|
February 2, 2018
Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRT
Shan-Shan Guo, Wen Hu, Qiu-Yan Chen, et al.
Oncotarget
|
April 23, 2016
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in stage III-IVb nasopharyngeal carcinoma patients with Epstein-Barr virus DNA ≥4000 copies/ml: a matched study
Shan-Shan Guo, Lin-Quan Tang, Qiu-Yan Chen, et al.
Journal of Cancer
|
November 19, 2019
The impact of Adult Comorbidity Evaluation-27 on the clinical outcome of elderly nasopharyngeal carcinoma patients treated with chemoradiotherapy or radiotherapy: a matched cohort analysis
Yue-Feng Wen, Xue-Song Sun, Li Yuan, et al.
Endoscopy
|
October 13, 2025
A rural-to-center artificial intelligence model for diagnosing Helicobacter pylori infection and premalignant gastric conditions using endoscopy images captured in routine practice
Tsung-Hsien Chiang, Yen-Ning Hsu, Min-Han Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2022
Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority Trial
Xiao-Yun Li, Dong-Hua Luo, Ling Guo, et al.
Page
of 64